Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 1,180,176 |
|
|||||
| News | - | ||||||
| Day High | 64.63 | Low High |
|||||
| Day Low | 64.56 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Alpine Immune Sciences Inc | ALPN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.02 | 0.03% | 64.57 | 17:02:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 64.57 | 64.56 | 64.63 | 64.57 | 64.55 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,503 | 1,180,176 | $ 64.59 | $ 76,222,176 | - | 6.71 - 64.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:06:55 | 3 | $ 64.55 | USD |
Alpine Immune Sciences (ALPN) Options Flow Summary
Alpine Immune Sciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.75B | 58.10M | - | 58.88M | -32.18M | -0.55 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alpine Immune Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALPN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 64.42 | 64.70 | 64.40 | 64.52 | 2,799,163 | 0.15 | 0.23% |
| 1 Month | 37.70 | 64.70 | 34.25 | 57.94 | 4,408,796 | 26.87 | 71.27% |
| 3 Months | 25.67 | 64.70 | 25.368 | 49.40 | 2,247,333 | 38.90 | 151.54% |
| 6 Months | 9.06 | 64.70 | 8.33 | 39.10 | 1,538,530 | 55.51 | 612.69% |
| 1 Year | 7.11 | 64.70 | 6.71 | 35.11 | 898,489 | 57.46 | 808.16% |
| 3 Years | 12.25 | 64.70 | 4.82 | 30.14 | 367,230 | 52.32 | 427.10% |
| 5 Years | 6.75 | 64.70 | 2.05 | 26.05 | 276,334 | 57.82 | 856.59% |
Alpine Immune Sciences Description
| Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202. |
